UNDERSTANDING MOLECULAR RECOGNITION:
SMALL MOLECULES AS ENZYME INHIBITORS AND TARGETS FOR DNA APTAMERS
Dr. Stevan Pecic
Dr. Stevan Pecic received a Dipl. Pharm. degree from The University of Belgrade in Serbia. He then obtained his doctorate degree in Biochemistry with concentration in Medicinal Chemistry from The Graduate School and University Center of The City University of New York advised by Dr. Wayne W. Harding. During his graduate work, Dr. Pecic studied natural products aporphines as serotonin receptor antagonists and acetylcholinesterase inhibitors. For the next 8 years, he continued his career as an Associate Research Scientist at Columbia University Medical Center in the Division of Experimental Therapeutics where he gained experience in the designing nucleic acid-based biosensors. He has also been a lead chemist on soluble epoxide hydrolase inhibitors (sEHI) project. During this period Dr. Pecic has authored many peer-reviewed publications and holds a patent related to the inhibitors of the enzyme soluble epoxide hydrolase (sEH). Dr. Stevan Pecic joined The Department of Chemistry and Biochemistry at California State University, Fullerton in 2018. as an Assistant Professor of Chemistry and Biochemistry.